Reproduced from Brilliant Pharmaceutical

On the morning of April 9, Vice Governor Wang Yihong of Sichuan Provincial People's Government, accompanied by Wu Qi, head of the Provincial Healthcare Security Administration, visited Chengdu Brilliant Pharmaceutical Group to investigate the group's participation in the pilot work of nationally centralized procurement of medicines and the related progress.

Vice Governor Wang Yihong and his team visited the Shuangliu production site of Chengdu Brilliant Pharmaceutical Group, and listened to its Chairman Su Zhonghai's report on the production, supply and quality assurance of the two "4+7" bid-winning drugs: Beixin and Baxin, as well as the construction progress of centralized production base for the state's small varieties of medicines (medicines under shortage). Besides, he learned in detail about the difficulties and challenges faced by the company, its production and operation status in recent years, and its development plan for the future.

Vice Governor Wang Yihong fully affirmed Brilliant Pharmaceutical's active participation in the state's pilot reform in centralized procurement of medicines, and its thoughtful arrangements in quality control, production, circulation and supply guarantee. He pointed out that the pilot project in centralized medicine procurement and use is a major strategic initiative made by the CPC Central Committee and the State Council, and is a critical reform of the current drug procurement model; enterprises shall change their mindsets, adapt to the needs of reform, and follow high standards and strict requirements to strengthen internal management, ensure the supply and quality of the selected drugs, to further establish corporate image; shall seize opportunities, increase input in research and development, stick to the development path of innovation, grow bigger and stronger, and safeguard people's health with quality medical services.